Search

everythinglearnresearchcommunity

for

Search:↓

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Some plants may help with hair growth and have fewer side effects than synthetic drugs, but more research is needed to confirm their effectiveness.

Use finasteride, minoxidil, and follicular unit transplantation for hair loss treatment.

Melatonin may help treat PCOS symptoms in rats.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Oral contraceptives can cause skin issues like dark patches, acne, yeast infections, sensitivity to light, spider veins, skin rashes, and hair loss.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

The skin is the largest organ, protecting the body, regulating temperature, and producing hormones.

Neurosteroids change how GABA_A receptors work in the brain, which could be important for treating temporal lobe epilepsy.

Minoxidil helps regrow hair in female pattern hair loss, but more research needed for other treatments.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

New treatments aim to improve thin endometrium to help more couples with infertility.

Testosterone replacement therapy can prevent men from fathering children and should not be used by those wanting to stay fertile.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

Herbs can potentially treat hair loss by inhibiting a key enzyme and promoting hair growth, and deficiencies in zinc, biotin, and iron are linked to hair loss.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

Finasteride may cause sexual side effects like erectile dysfunction, but they are reversible and affect less than 2% of men.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Some men with early hair loss may have a condition similar to PCOS in women.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Reproductive factors can increase hypertension risk and affect cardiovascular health.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.